Search

Home > Diabetes Knowledge into Practice Podcast > Newsflash | Glaucoma risk with GLP-1 RAs
Podcast: Diabetes Knowledge into Practice Podcast
Episode:

Newsflash | Glaucoma risk with GLP-1 RAs
Category: Health
Duration: 00:02:56
Publish Date: 2021-10-05 13:24:21
Description:

Hear a 5-minute summary of a retrospective study investigating whether GLP-1 receptor agonists might affect the development of glaucoma in people with diabetes, published in the British Journal of Ophthalmology. Listen for a quick overview of the key findings.


References:

Publication: Sterling J, et al. Glucagon-like peptide 1 receptor agonist use is associated with reduced risk for glaucoma. Br J Ophthalmol. 2021 Aug 19:bjophthalmol-2021-319232. Epub ahead of print.

Additional references: Zhao YX, Chen XW. Diabetes and risk of glaucoma: systematic review and a Meta-analysis of prospective cohort studies. Int J Ophthalmol. 2017 Sep 18;10(9):1430-1435.

Sterling JK, et al. GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension. Cell Rep. 2020 Nov 3;33(5):108271.

For more free education, visit the DKIP website, follow us on Twitter (@dkipractice) or connect on LinkedIn. 

Target Audience

This educational activity is intended for an international audience of non-US and non-UK HCPs.

Funding statement:

This independent educational activity is supported by an educational grant from Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Novo Nordisk A/S has had no influence on the content of this education.
Total Play: 0